One Zyme
Founded 2025 · 7 employees on LinkedIn · 4 known investors
Find your way into One Zyme
765 people in our graph share verified history with the One Zyme team — schools, employers, funds. One of them is your warm intro.
Kyle Dohertyunlockedknows Aaron Michel · together at Harvard Business School (overlapped)
×6knows the team · via Harvard University
×4knows the team · via Harvard Business School
knows the team · via Boston University
One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
Founders & leadership
One Zyme was founded in 2025 by Aaron Michel.
AM
Aaron Michelin𝕏Co-Founder and CEOAaron Michel previously founded PathSource, which was acquired in 2017, and has invested in multiple early-stage companies. He serves as founder of One Zyme, an AI platform for life sciences intelligence.
Investors · 4
Frequently asked questions
- What does One Zyme do?
- One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
- Who founded One Zyme?
- One Zyme was founded by Aaron Michel in 2025.
- Who are One Zyme's investors?
- One Zyme's investors include Invariantes Fund, Newfund Capital, Service Provider Capital, TMV.